http://venturebeat.com/2007/08/06/daily-life-sciences-deal-briefing-monday-august-6-2007/ News About Tech, Money and Innovation Mon, 23 Nov 2009 10:55:42 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/08/06/daily-life-sciences-deal-briefing-monday-august-6-2007/comment-page-1/#comment-569662 VentureBeat » Life sciences briefing: Monday, Oct. 8, 2007 Tue, 09 Oct 2007 09:12:59 +0000 http://venturebeat.com/2007/08/06/daily-life-sciences-deal-briefing-monday-august-6-2007/#comment-569662 [...] many as 6.9 million shares at a price of €5.75 to €7.25 apiece. We last wrote about the company here. For more stories on VentureBeat Life Sciences, click here.Tagged anti infective drugs, anti [...] [...] many as 6.9 million shares at a price of €5.75 to €7.25 apiece. We last wrote about the company here. For more stories on VentureBeat Life Sciences, click here.Tagged anti infective drugs, anti [...]

]]> http://venturebeat.com/2007/08/06/daily-life-sciences-deal-briefing-monday-august-6-2007/comment-page-1/#comment-545834 VentureBeat » Life sciences briefing: Friday, Sept. 21, 2007 Fri, 21 Sep 2007 15:08:00 +0000 http://venturebeat.com/2007/08/06/daily-life-sciences-deal-briefing-monday-august-6-2007/#comment-545834 [...] raised a $10 million “debt facility” in August (see our coverage in the second item here). For more stories on VentureBeat Life Sciences, click here.Tagged asthma, co:454 Life Sciences, [...] [...] raised a $10 million “debt facility” in August (see our coverage in the second item here). For more stories on VentureBeat Life Sciences, click here.Tagged asthma, co:454 Life Sciences, [...]

]]>